Blockade of SARS-CoV-2 spike protein-mediated cell–cell fusion using COVID-19 convalescent plasma
Abstract The recent COVID-19 pandemic poses a serious threat to global public health, thus there is an urgent need to define the molecular mechanisms involved in SARS-CoV-2 spike (S) protein-mediated virus entry that is essential for preventing and/or treating this emerging infectious disease. In th...
Guardado en:
Autores principales: | Ling Wang, Juan Zhao, Lam N. T. Nguyen, James L. Adkins, Madison Schank, Sushant Khanal, Lam N. Nguyen, Xindi Dang, Dechao Cao, Bal Krishna Chand Thakuri, Zeyuan Lu, Jinyu Zhang, Yi Zhang, Xiao Y. Wu, Mohamed El Gazzar, Shunbin Ning, Jonathan P. Moorman, Zhi Q. Yao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/65f0c6e757e64853a3c6e721271fd6cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
LncRNA HOTAIRM1 promotes MDSC expansion and suppressive functions through the HOXA1-miR124 axis during HCV infection
por: Bal Krishna Chand Thakuri, et al.
Publicado: (2020) -
Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children
por: Melanie R. Neeland, et al.
Publicado: (2021) -
Sustained expression of inflammatory monocytes and activated T cells in COVID‐19 patients and recovered convalescent plasma donors
por: Ravinder Singh, et al.
Publicado: (2021) -
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade
por: Qi Peng, et al.
Publicado: (2020) -
Convalescent Plasma for the Treatment of Severe COVID-19
por: Franchini M, et al.
Publicado: (2021)